1 asset in Hereditary Gingival Fibromatosis
Therapeutic assets addressing Hereditary Gingival Fibromatosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Vebreltinib Hereditary Gingival Fibromatosis | Apollomics Inc. | P2 | CCC (53) |